While The Trade Desk closed its last fiscal year with a solid increase in profit, the advertising technology specialist is currently navigating a challenging en ...

A leading global investment bank has identified a standout contender in China's competitive artificial intelligence landscape. Morgan Stanley analysts reaffirm ...

The standalone listing of Class Limited on the Australian exchange has now concluded. Following its acquisition by platform provider HUB24 Limited, the company ...

Pharmaceutical giant Eli Lilly is executing a simultaneous two-front strategy to solidify its commanding position in the multi-billion dollar weight-loss drug m ...

Wall Street’s attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases. While clinical development progresses according to schedule, a fresh ...

In times of heightened market volatility, asset manager Schroders is advocating for a steady hand. The firm’s leadership is ...

D-Wave Quantum Inc. presents a complex financial picture, marked by explosive annual growth overshadowed by a disappointing ...

Oracle Corporation delivered a quarterly report that exceeded even the most bullish expectations on Wall Street. The ...

A series of high-level personnel and strategic developments at The Trade Desk are presenting a mixed picture to the market.

The biotechnology giant CSL is making a substantial strategic move, channeling $1.5 billion into a major expansion of its U.S. manufacturing footprint. This lon ...

In periods of bond market volatility, investors often seek strategies that can potentially generate returns regardless of the broader economic cycle. The CI Mar ...

The Australian medical technology sector is undergoing a significant reassessment, and its leading player, Cochlear, finds itself squarely in the spotlight. Des ...